drug specific delivery device; adaptive clinical trial; article; autoimmune disease; blockchain; cancer mortality; chronic pain; clinical pathway; clinical trial (topic); coronavirus disease 2019; defense mechanism; disease marker; drug delivery system; drug development; drug industry; epigenetics; experimental therapy; gene therapy; genomics; health care cost; human; machine learning; metabolomics; Parkinson disease; personalized medicine; phase 3 clinical trial (topic); placebo effect; process optimization; proteomics; treatment response